BRAF and thyroid cancer: Sporadic thyroid cancers usually develop via abnormal activation of the RAS-RAF-MEK-ERK signaling pathway (MAPK; which relays signals from cell membrane to nucleus), primarily as a result of point mutations in the RAS/BRAF genes or chromosomal rearrangements such as RET/PTC translocations [1].